Citation: | ZHANG Hongrong, XU Qi, MA Zhongmin, et al. Artificial intelligence-based systematic study on the multidimensional pharmacological activity and molecular mechanism of the active ingredients of Artemisia argyi[J]. J China Pharm Univ, 2025, 56(3): 358 − 367. DOI: 10.11665/j.issn.1000-5048.2024080701 |
To investigate the pharmacological activities and potential mechanisms of action of the active components in Artemisia argyi with artificial intelligence technology, a search was conducted in the HIT, TCMSP, and TCMIO databases, obtaining 199 active components of A. argyi. A comprehensive set of algorithms, including KNN, MLP, RF, SVM, and models based on Lipinski’s and Veber’s rules, was employed to predict the toxicity and oral bioavailability of A. argyi compounds, identifying 14 components that are non-toxic and have good oral bioavailability. The synthetic accessibility score (SAscore) model was used to analyze the synthetic accessibility of the 14 components mentioned above, and molecular segments were fragmented using BRICS and RECAP algorithms. Mining of the STP and PM databases yielded 406 target proteins for the core components of A. argyi, and Cytoscape was used to screen out 5 core targets: SRC, EGFR, PTPN11, HRAS, and PDGFRB. GO and KEGG enrichment analyses indicated that the core targets were involved in 808 GO enrichment analysis entries and 71 signaling pathways, including EGFR tyrosine kinase inhibitor resistance, gap junction, phospholipase D, and JAK/STAT. Molecular docking results showed that active compounds of A. argyi have a good binding affinity with proteins SRC, EGFR, PTPN11, and HRAS. Cellular experiments have confirmed that ledol, an active component of A. argyi, can promote the proliferation of HUVEC cells within a certain concentration range and can increase the expression of EGFR protein. This study reveals the pharmacological characteristics and potential molecular mechanisms of the active components of A. argyi and lays a solid scientific foundation for its medicinal development.
[1] |
Wang JL, Guo QT, Zhang J, et al. Artemisia argyi and its application in traditional Chinese medicine agriculture[J]. Mod Horticult(现代园艺), 2024, 47(17): 80-82.
|
[2] |
Erdenebileg S, Kim M, Nam Y, et al. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling[J]. J Ethnopharmacol, 2024, 333: 118415.
|
[3] |
Zhang XJ. Artificial intelligence-driven pharmaceutical industry upgrade, capital rushes to AI-powered drug discovery and development[N]. Econic Inform Daily(经济参考报), 2024-06-05(003).
|
[4] |
Di Stefano M, Galati S, Piazza L, et al. VenomPred 2.0: a novel in silico platform for an extended and human interpretable toxicological profiling of small molecules[J]. J Chem Inf Model, 2024, 64(7): 2275-2289. doi: 10.1021/acs.jcim.3c00692
|
[5] |
Sharma S, Pandey KM. Computational bioprospecting of phytoconstituents as potential inhibitors for peptide deformylase from Streptococcus oralis: an opportunistic pathogen[J]. Arch Biochem Biophys, 2024, 758: 110079. doi: 10.1016/j.abb.2024.110079
|
[6] |
Kerstjens A, De Winter H. Molecule auto-correction to facilitate molecular design[J]. J Comput Aided Mol Des, 2024, 38(1): 10. doi: 10.1007/s10822-024-00549-1
|
[7] |
Calvi A, Gaudin T, Miketa D, et al. Leap: molecular synthesisability scoring with intermediates[EB/OL]. 2024: 2403.13005. https://arxiv.org/abs/2403.13005v2.
|
[8] |
Skoraczyński G, Kitlas M, Miasojedow B, et al. Critical assessment of synthetic accessibility scores in computer-assisted synthesis planning[J]. J Cheminform, 2023, 15(1): 6. doi: 10.1186/s13321-023-00678-z
|
[9] |
Li JY, Liu T, Sun F, et al. Therapeutic effect and mechanism of hordenine on ovalbumin-induced allergic rhinitis in rats[J]. J China Pharm Univ(中国药科大学学报), 2025, 56(1): 80-90.
|
[10] |
Xu MM, Ren L, Fan JH, et al. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6[J]. Life Sci, 2022, 290: 120266. doi: 10.1016/j.lfs.2021.120266
|
[11] |
Jiang ZY, You QD. Assistance of artificial intelligence in new drug development[J]. J China Pharm Univ(中国药科大学学报), 2024, 55(3): 281-283.
|
[12] |
Zhu JQ, Zhou X, Hou F, et al. DLGCN: Prediction of drug-lncRNA associations based on graph convolution network[J]. Chin J Bioinform(生物信息学), 2024, 22(2): 93-100.
|
[13] |
Jiang XJ, Chen YH, Song Z, et al. Research progress in the pharmacology and mechanism of Artemisia argyi[J]. Acta Medicinae Sinica(华夏医学), 2023, 36(6): 182-188.
|
[14] |
Zhang XF, Zeng YX, Zhou LP, et al. Preliminary study on optimization of extraction process and antioxidant activity of total flavonoids from Artemisia argyi leaves[J]. Ind Microbiol(工业微生物), 2024, 54(1): 134-136.
|
[15] |
Zhang XY, Chen H, Wang Z, et al. Status of application of machine learning algorithm in drug toxicity prediction[J]. Chin J New Drug(中国新药杂志), 2024, 33(2): 110-117.
|
[16] |
Haritha M, Sreerag M, Suresh CH. Quantifying the hydrogen-bond propensity of drugs and its relationship with Lipinski’s rule of five[J]. New J Chem, 2024, 48(11): 4896-4908. doi: 10.1039/D3NJ05476D
|
[17] |
Zeng H, Wu GZ, Zou WX, et al. Optimization of Menin inhibitors based on artificial intelligence-driven molecular factory technology[J]. J China Pharm Univ(中国药科大学学报), 2024, 55(3): 326-334.
|
[18] |
Wen HQ, Sun QH, Shen WF. Targeted intelligent molecular generation framework based on fragments chemical space[J]. Ciesc J(化工学报), 2024, 75(4): 1655-1667.
|
[19] |
Wang JJ, Cui WF, Dou XW, et al. Euonymus alatus delays progression of diabetic kidney disease in mice by regulating EGFR tyrosine kinase inhibitor resistance signaling pathway[J]. J S Med Univ(南方医科大学学报), 2024, 44(7): 1243-1255.
|
[20] |
Cheng XD, Zhou H, Zhou Y, et al. M2 macrophage-derived exosomes inhibit apoptosis of HUVEC cell through regulating miR-221-3p expression[J]. Biomed Res Int, 2022, 2022: 1609244. doi: 10.1155/2022/1609244
|
[21] |
Xu WM, Qian JJ, Xu Q, et al. Proteins and signaling pathways response to Wenjingtongluo drug-contained serum in IHUVECs: an explorative proteomic study[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(6): 116-124. doi: 10.14715/cmb/2023.69.6.18
|
[22] |
Xue H, Dong L, Yang PS, et al. Effects of Tiaojing Cuyun prescription on endometrial receptivity and AREG/EGFR/HIF-1α signaling pathway in embryo implantation dysfunction infertility mice[J]. Chin J Inform TCM(中国中医药信息杂志), 2024, 31(10): 74-80.
|
[1] | FENG Yanchun, PEI Wenli, NING Baoming, SHI Jifeng. Development and application of chemical reference materials[J]. Journal of China Pharmaceutical University, 2024, 55(5): 715-720. DOI: 10.11665/j.issn.1000-5048.2023122402 |
[2] | XIAO Ting, MA Bufang, WANG Chen, YAO Shangchen, FENG Yanchun, NING Baoming. Evaluation on measurement uncertainty of correction factors of fluconazole impurities determined by HPLC standard curve method[J]. Journal of China Pharmaceutical University, 2022, 53(3): 306-313. DOI: 10.11665/j.issn.1000-5048.20220308 |
[3] | XIAO Ting, WANG Chen, TIAN Ye, ZHANG Xia, LIU Ying, MA Bufang, LIU Shuyu, YAO Shangchen, FENG Yanchun. Establishment of national reference standard of tazobactam impurity A[J]. Journal of China Pharmaceutical University, 2021, 52(1): 60-65. DOI: 10.11665/j.issn.1000-5048.20210108 |
[4] | Standardization on quality evaluation of 16 Chinese medicinal materials[J]. Journal of China Pharmaceutical University, 2002, (4): 3-5. |
[5] | Study on Quality Standard of Clindamycin Phosphate for injection[J]. Journal of China Pharmaceutical University, 2000, (3): 52-54. |
[8] | Studies on Quality Standard for Shuangliao Houfeng Tablets[J]. Journal of China Pharmaceutical University, 1995, (5): 268-272. |
[9] | Study on the Quality Control of Wangshi Baochi Pills[J]. Journal of China Pharmaceutical University, 1995, (2): 68-71. |
[10] | Determination of Synthetic Decanoyl Acetaldehyde in Compound Chinese Medicines by Standard Addition Method of UV Second Order Derivative Spetrum[J]. Journal of China Pharmaceutical University, 1994, (2): 96-99. |